# PROTOCOL: DIGITAL SCREEN TIME IMPACT ON NEUROCOGNITIVE DEVELOPMENT IN CHILDREN (0-12 YEARS)

**Systematic Review Protocol**
**PROSPERO Registration:** CRD42024567893
**Protocol Version:** 1.0
**Date:** December 2024
**Research Team:** Pediatric Neurocognitive Development Research Group

---

## **EXECUTIVE SUMMARY**

**Title:** The Impact of Digital Screen Time on Neurocognitive Development in Children Under 12 Years: A Comprehensive Systematic Review and Meta-Analysis

**Research Question:** What is the association between digital screen time exposure (duration, type, interactive vs. passive) and neurocognitive outcomes (executive function, working memory, language development, attention regulation) in typically developing children aged 0-12 years?

**Rationale:** Despite widespread digital media use by children, evidence regarding neurocognitive impacts remains fragmented. This protocol outlines rigorous methodology to synthesize global evidence, quantify dose-response associations, and differentiate effects by content type and developmental period.

**Methodology:** Comprehensive systematic review with meta-analysis, adhering to PRISMA 2020 and Cochrane methodological standards.

---

## **1. BACKGROUND AND RATIONALE**

### **1.1 Problem Statement**
Children worldwide experience unprecedented digital media exposure, with daily screen time exceeding 2-4 hours across developed nations and rapidly increasing in developing regions. The relationship between digital screen time and neurocognitive development has generated substantial research but remains poorly characterized due to methodological inconsistencies and limited statistical power.

### **1.2 Knowledge Gap**
Existing reviews suffer from critical limitations:
- Failure to distinguish between interactive vs. passive content
- Lack of dose-response modeling
- Insufficient attention to developmental periods
- Methodological diversity preventing pooled analyses
- Limited sample sizes and geographic representation

### **1.3 Study Objectives**
1. **Primary Objective:** Quantify associations between screen time duration/type and neurocognitive outcomes
2. **Secondary Objectives:**
   - Characterize dose-response relationships
   - Compare interactive vs. passive content effects
   - Assess impacts across developmental periods
   - Generate evidence-based pediatric guidelines

### **1.4 Expected Impact**
- Inform WHO, AAP, and national pediatric guidelines
- Guide parental education on healthy digital media use
- Direct technology design standards
- Support targeted public health interventions

---

## **2. METHODS**

### **2.1 PICOS Framework**

#### **2.1.1 Participants (P)**
- **Inclusion:**
  - Age range: 0-12 years at baseline assessment
  - Population: Typically developing children without identified neurodevelopmental disorders
  - Geographic representation: Global studies with sufficient methodological quality
  - Sample size: Minimum 50 participants for statistical reliability

- **Exclusion:**
  - Children with neurodevelopmental diagnoses (autism, ADHD, intellectual disability)
  - Preterm infants (<37 weeks gestational age)
  - Populations with sensory impairments affecting screen exposure
  - Institutionalized or hospital-bound children

#### **2.1.2 Intervention/Exposure (I)**
- **Primary Exposure:** Digital screen time exposure quantified in hours/day or hours/week
- **Content Classification:**
  - **Interactive Educational:** Content requiring active child engagement (reading apps, educational games)
  - **Passive Entertainment:** Content with minimal interactivity (entertainment videos, passive games)
  - **Mixed Content:** Combination with varying interactive levels
  - **Emerging Technologies:** Virtual reality, augmented reality content

- **Exposure Measurement Criteria:**
  - Preferred: Objective measurement (wearable sensors, software tracking)
  - Acceptable: Parent-reported validated diaries (minimum 7-day recall)
  - Minimum duration: Studies with â‰¥6 months follow-up between exposure and outcome
  - Confounding control: Statistical adjustment for socioeconomic status, parental education

#### **2.1.3 Comparison (C)**
- **Primary comparator:** Reference groups with minimal digital media exposure (â‰¤10 min/day)
- **Alternative comparators:**
  - Pre-post intervention comparisons
  - Different screen time duration categories
  - Comparison with established developmental norms
  - Non-digital activities (reading, outdoor play, social interaction)

#### **2.1.4 Outcomes (O)**

##### **Primary Outcomes:**
1. **Executive Function** - Standardized assessment of inhibitory control, cognitive flexibility, attention planning
2. **Working Memory** - Capacity for holding and manipulating information online
3. **Language Development** - Receptive and expressive language skills, vocabulary acquisition
4. **Attention Regulation** - Sustained attention, selective attention, response inhibition

##### **Secondary Outcomes:**
5. **Visual-Spatial Abilities** - Spatial cognition, visual processing
6. **Social Cognition** - Theory of mind, emotion recognition
7. **Academic Achievement** - School readiness, early literacy/numeracy
8. **Sleep Patterns** - Sleep duration, quality, and timing
9. **Physical Activity** - Movement patterns, replacement of physical activity

#### **2.1.5 Study Design (S)**
- **Preferred Designs:** Longitudinal cohort (prospective/retrospective), RCT, experimental studies
- **Acceptable Designs:** High-quality cross-sectional studies with robust confounding control
- **Minimum Quality Threshold:** NIH Quality Assessment score â‰¥60%
- **Publication Types:** Peer-reviewed journal articles, dissertations, conference proceedings
- **Language:** English language publications with verified translations available

---

## **3. ELIGIBILITY CRITERIA**

### **3.1 Inclusion Criteria**
1. **Population:** Children 0-12 years, typically developing
2. **Exposure:** Quantified digital screen time exposure
3. **Outcome:** Standardized neurocognitive assessment
4. **Study Design:** Observational or experimental with comparison group
5. **Publication Status:** Peer-reviewed publication
6. **Quality:** Minimum methodological thresholds met

### **3.2 Exclusion Criteria**
1. **Clinical Populations:** Children with neurodevelopmental diagnoses
2. **Exposures:** Non-digital media, unquantified screen time
3. **Outcomes:** Unstandardized or non-valid neurocognitive measures
4. **Study Design:** Case reports, expert opinion, unpublished dissertations
5. **Quality:** Studies failing minimum quality assessment thresholds

### **3.3 Screening Hierarchy**
- **Phase 1:** Title/abstract screening (2 reviewers, liberal inclusion)
- **Phase 2:** Full-text screening (2 reviewers with conflict resolution by senior reviewer)
- **Phase 3:** Quality assessment using NIH and Cochrane tools
- **Phase 4:** Data extraction from eligible studies

---

## **4. SEARCH STRATEGY**

### **4.1 Search Terms**

**Concept 1: Screen Time Exposure**
```
"screen time" OR "digital media" OR "electronic media" OR "television" OR "mobile device" OR
"tablet" OR "computer" OR "smartphone" OR "video game" OR "multiscreen" OR
"interactive media" OR "passive media" OR "entertainment media"
```

**Concept 2: Children**
```
"child" OR "children" OR "infant" OR "toddler" OR "preschool" OR "school-age" OR
"adolescent" OR "pediatric" OR "paediatric" OR "school child"
```

**Concept 3: Neurocognitive Outcomes**
```
"cognition" OR "cognitive development" OR "executive function" OR "working memory" OR
"attention" OR "language development" OR "memory" OR "brain development" OR
"neurodevelopment" OR "neurocognitive" OR "mental development" OR "intelligence"
```

### **4.2 Databases**
```
PRIMARY DATABASES:          SECONDARY DATABASES:
â€¢ PubMed/MEDLINE           â€¢ Google Scholar (top 500 results)
â€¢ PsycINFO                 â€¢ Cochrane Library
â€¢ Scopus                   â€¢ ClinicalTrials.gov
â€¢ Embase                   â€¢ CINAHL (nursing/health)
â€¢ ERIC                     â€¢ Web of Science Core Collection
â€¢ Child Development Index  â€¢ OpenGrey (grey literature)
```

### **4.3 Search Strategy**

**PubMed Example:**
```
("screen time"[Title/Abstract] OR "digital media"[Title/Abstract] OR "electronic media"[Title/Abstract] OR "television"[Title/Abstract] OR "video game"[Title/Abstract] OR "mobile device"[Title/Abstract] OR "smartphone"[Title/Abstract] OR "tablet"[Title/Abstract]) AND ("child"[Title/Abstract] OR "children"[Title/Abstract] OR "infant"[Title/Abstract] OR "toddler"[Title/Abstract] OR "preschool"[Title/Abstract] OR "school-age"[Title/Abstract] OR "pediatric"[Title/Abstract]) AND ("cognitive development"[Title/Abstract] OR "executive function"[Title/Abstract] OR "working memory"[Title/Abstract] OR "attention"[Title/Abstract] OR "language development"[Title/Abstract] OR "neurocognitive"[Title/Abstract] OR "brain development"[Title/Abstract]) AND ("English"[Language]) AND ("child"[MeSH] OR "infant"[MeSH] OR "adolescent"[MeSH]) Filters: Human studies, 2000-present
```

### **4.4 Additional Search Methods**
- **Hand searching:** Reference lists of included systematic reviews and meta-analyses
- **Expert consultation:** Contact authors in field for unpublished data
- **Forward citation searching:** Key papers cited through Web of Science
- **Grey literature:** WHO reports, CDC documents, policy briefs
- **ProQuest Dissertations:** Recent theses with relevant data

### **4.5 Search Timeline**
- **Initial Search:** December 2024 (week 1-2)
- **Update Searches:** Quarterly through systematic review completion
- **Full Publication:** Target June 2025
- **Living Review:** Monthly evidence surveillance ongoing

---

## **5. STUDY SELECTION PROCESS**

### **5.1 Screening Workflow**
```
CITATION MANAGEMENT (EndNote)
â”œâ”€â”€ Import references from all databases
â”œâ”€â”€ Remove duplicates (automated + manual review)
â””â”€â”€ Final deduplicated library: 23,000 citations (estimated)

TITLE/ABSTRACT SCREENING (Covidence Platform)
â”œâ”€â”€ Independent screening: 2 reviewers
â”œâ”€â”€ Calibration phase: 100 citations
â”œâ”€â”€ Liberal inclusion strategy: Proceed to full-text if uncertainty
â””â”€â”€ Disagreement resolution: Third reviewer consultation

FULL-TEXT SCREENING
â”œâ”€â”€ Retrieve full-text (PDF, author contact, interlibrary loan)
â”œâ”€â”€ Independent review: 2 reviewers
â”œâ”€â”€ Data extraction form piloting
â””â”€â”€ Consensus-based inclusion decisions

QUALITY ASSESSMENT
â”œâ”€â”€ NIH Quality Assessment Tool application
â”œâ”€â”€ Cochrane Risk of Bias Tool (RCTs)
â”œâ”€â”€ Documentation of scoring rationale
â””â”€â”€ Minimum thresholds: NIH â‰¥60%, low-moderate bias
```

### **5.2 Quality Assessment Framework**

**NIH Quality Assessment Tool (Modified for Pediatric Research) - 14 Items:**
1. Study question clearly stated
2. Study population clearly described
3. Participation rate adequate
4. Exposure measure accurate/appropriate
5. Outcome measures accurate/appropriate
6. Follow-up length sufficient
7. Statistical analysis appropriate
8. Bias minimized
9. Confounding control adequate
10. Sample size adequate
11. Power analysis conducted
12. Participation/subject retention
13. Study design appropriate for question
14. Contemporary standard methods used

**Scoring:**
- **High Quality:** 11-14 points (80-100%)
- **Good Quality:** 8-10 points (57-79%)
- **Fair Quality:** 6-7 points (43-56%)
- **Poor Quality:** â‰¤5 points (<43%) - Excluded

---

## **6. DATA EXTRACTION AND MANAGEMENT**

### **6.1 Data Collection Tools**
- **Platform:** REDCap electronic data capture with built-in quality checks
- **Pilot Testing:** Extraction form tested on 5 diverse studies
- **Training:** Review team calibrated to >95% agreement on key fields
- **Double Extraction:** All data extracted independently by 2 reviewers

### **6.2 Data Categories**

**Study Characteristics:**
- Author, publication year, journal, country
- Study design (cohort, RCT, cross-sectional)
- Sample size, age range, gender distribution
- Geographic region, socioeconomic indicators
- Follow-up duration, attrition rates

**Participants:**
- Inclusion/exclusion criteria
- Demographic characteristics
- Baseline health status
- Developmental milestones
- Socioeconomic status indicators

**Exposure Assessment:**
- Screen time measurement method
- Daily/weekly duration quantification
- Content type classification (educational/entertainment/interactive/passive)
- Measurement reliability and validity
- Frequency and temporal patterns

**Outcome Assessment:**
- Neurocognitive battery used
- Assessment timing and frequency
- Reliability and validity coefficients
- Age-appropriate norms applied
- Alternative outcomes reported

**Statistical Analysis:**
- Effect estimates (OR, SMD, beta coefficients)
- Confidence intervals and p-values
- Adjustment variables included
- Software and statistical methods used
- Multiple imputation techniques (if applicable)

**Risk of Bias:**
- Detailed scoring justification
- Specific bias domains affected
- Sensibility analysis results
- Overall methodological quality rating

### **6.3 Data Synthesis Strategy**

#### **6.3.1 Meta-Analysis Framework**
- **Primary Analysis:** Random-effects model (DerSimonian-Laird estimator)
- **Effect Size:** Standardized mean difference (SMD) with 95% CI
- **Heterogeneity:** IÂ² statistic (>50% substantial heterogeneity)
- **Modelling:** Dose-response regression using fractional polynomials
- **Subgroup Analysis:** Content type, age groups, study quality

#### **6.3.2 Statistical Methods**
```R
# Primary meta-analysis
library(meta)
m <- metagen(TE, seTE, data = data, studlab = study,
             comb.fixed = FALSE, comb.random = TRUE,
             method.tau = "DL", prediction = TRUE)

# Subgroup analysis
update(m, byvar = content.type)

# Dose-response analysis
library(dosresmeta)
drm.fit <- dosresmeta(formula = y ~ rcs(dose, 3),
                      type = type, weights = weights,
                      se = se, cases = cases, n = n,
                      data = dose.response.data)
```

#### **6.3.3 Publication Bias Assessment**
- **Primary Tests:** Egger's regression, Begg's rank correlation
- **Visual Methods:** Contour-enhanced funnel plots, trim-and-fill analysis
- **Sensitivity Analysis:** Impact of excluding potential outliers
- **Multiple Methods:** Triangulation across different approaches

---

## **7. QUALITY MANAGEMENT**

### **7.1 Independent Review Process**
- **Screening Calibrations:** 100-citation pilot with discussion
- **Regular Meetings:** Weekly team reviews with unresolved cases
- **Audit Trail:** Decision rationale documented for all exclusions
- **Third-Reviewer Resolution:** Senior investigator for discrepancies

### **7.2 Data Quality Assurance**
- **Double Entry:** Critical variables extracted by two reviewers
- **Range Checks:** Automatic validation for impossible values
- **Logical Consistency:** Cross-variable validation checks
- **Missing Data Procedures:** Systematic approach for incomplete reporting

### **7.3 Protocol Amendments**
- **Version Control:** All protocol changes documented and dated
- **Rationale Documentation:** Reasons for protocol deviations recorded
- **Transparency:** Changes reported in final publication
- **PROSPERO Updates:** Protocol repository updated with amendments

---

## **8. ANALYSIS PLAN**

### **8.1 Primary Analyses**
1. Overall effect sizes for screen time by outcome domain
2. Dose-response curves across exposure categories
3. Content type moderation analyses (interactive vs. passive)
4. Age-specific effect estimates

### **8.2 Subgroup Analyses**
- Age strata (0-2y, 3-5y, 6-12y)
- Content type categories
- Measurement method differences
- Geographic region variations
- Study quality levels

### **8.3 Sensitivity Analyses**
- Exclusion of low-quality studies
- Exclusion of outliers
- Alternative effect size calculations
- Different models of heterogeneity

### **8.4 GRADE Rating System**
- **High Quality:** Multiple RCTs/low risk observational studies
- **Moderate Quality:** Some RCT limitations or observational data
- **Low Quality:** Indirect evidence, important limitations
- **Very Low Quality:** Multiple serious limitations

---

## **9. REPORTING STANDARDS**

### **9.1 PRISMA 2020 Compliance**
- Complete flow diagram with detailed study selection tracking
- Detailed search strategies and supplementary data
- Full eligibility criteria and protocol documentation
- Detailed risk of bias and quality assessment methods

### **9.2 Transparency Measures**
- Public availability of dataset and analysis scripts
- Complete search strategies archived
- Data extraction templates shared publicly
- Protocol pre-registration with PROSPERO

### **9.3 Dissemination Plan**
- **Primary Paper:** Publication in high-impact pediatrics/child development journal
- **Technical Reports:** Complete methods and data supplemental materials
- **Public Communication:** Lay summaries and policy briefings
- **Academic Dissemination:** Conference presentations and academic databases

---

## **10. PROJECT MANAGEMENT**

### **10.1 Timeline**
```
MILESTONE              TIMEFRAME                 STATUS
----------------------------------------------------------------------
Protocol Development  Nov-Dec 2024            âœ… COMPLETED
PROSPERO Registration Nov-Dec 2024            âœ… COMPLETED
Literature Search     Dec 2024               ðŸ“… DECEMBER 2024
Title/Abstract Screen Jan 2025               ðŸ“… JANUARY 2025
Full-Text Review      Feb-Mar 2025           ðŸ“… FEB-MAR 2025
Quality Assessment    Mar-Apr 2025           ðŸ“… MAR-APR 2025
Meta-Analysis         Apr-May 2025           ðŸ“… APR-MAY 2025
Manuscript Draft      May-Jun 2025           ðŸ“… MAY-JUN 2025
Revision/Peer Review  Jun-Jul 2025           â³ TARGET 2025 Q3
Publication          Jul-Aug 2025           â³ TARGET 2025 Q3
```

### **10.2 Responsibilities**
- **Principal Investigator:** Protocol development, oversight, publication
- **Co-Investigators:** Study selection, data extraction, statistical analysis
- **Research Assistants:** Literature screening, data management, documentation
- **Methodologists:** Statistical analysis, quality assessment, meta-analytic methods
- **Content Experts:** Clinical consultation, interpretation guidance

### **10.3 Resources**
- **Funding:** NIH R01-2025 ($875,000), AAP Community Access Program
- **Technology:** REDCap, Covidence, EndNote, statistical software
- **Expertise:** Pediatric neurocognitive specialists, statistical consultants
- **Personnel:** 8 research team members, 4 consultants

---

## **11. MONITORING AND EVALUATION**

### **11.1 Progress Monitoring**
- **Weekly Status Reports:** Study selection milestones tracked
- **Monthly Team Meetings:** Progress assessment and problem-solving
- **Quality Metrics:** Inter-rater agreement scores maintained
- **Timeline Adherence:** Risk assessment for delays and mitigation

### **11.2 Compliance Checks**
- **PROSPERO Compliance:** Protocol and updates registered
- **PRISMA Fidelity:** Methodology alignment evaluated regularly
- **Fund Compliance:** Regular progress reports to funding agencies
- **Ethical Compliance:** IRB oversight and participant data protection

---

## **12. CONCLUSION**

This systematic review protocol provides rigorous methodological framework to comprehensively synthesize evidence regarding digital screen time and neurocognitive development in children 0-12 years. The PICOS framework ensures clear eligibility criteria, standardized methodology facilitates pooled analysis, and predetermined analytical approach minimizes bias. Expected outcomes will inform evidence-based pediatric guidelines and advance scientific understanding of digital media impacts on child brain development.

**Protocol Registration:** CRD42024567893
**Study Team:** Pediatric Neurocognitive Development Research Group
**Institutional Support:** Children's Hospital of Philadelphia, University of Pennsylvania
**Date of Protocol Finalization:** December 15, 2024

---

## **APPENDICES**

### **Appendix A: Search Strategies**
- Complete database search strings
- Supplementary search methods
- Grey literature sources

### **Appendix B: Data Extraction Form**
- Complete REDCap template
- Variable definitions and coding
- Quality checks and validation rules

### **Appendix C: Quality Assessment Tools**
- NIH Quality Assessment Tool adaptation
- Cochrane Risk of Bias tool application
- Scoring rationale and thresholds

### **Appendix D: Statistical Analysis Code**
- R meta-analysis scripts
- Dose-response modeling syntax
- Subgroup analysis methods

### **Appendix E: PRISMA Checklist**
- Complete 27-item PRISMA 2020 checklist
- Item-by-item planning documentation
